Hans Clevers

Direktör/Styrelseledamot på

F. Hoffmann-La Roche Ltd.

69 år

79 relationer

Health Technology

Commercial Services

Finance

Profil

Hans Clevers is the founder of Surrozen Operating, Inc. (2015) and Xilis, Inc. (2019).
Current jobs include Director at F.
Hoffmann-La Roche Ltd. (2019) and Professor-Molecular Genetics at the University of Utrecht (2002).
Former jobs include Director at Genentech, Inc., Director at the American Association for Cancer Research (2012-2015), Director-Royal Netherlands Academy at Hubrecht Institute (2002-2012), Research Director at Princess Maxima Centre For Pediatric Oncology (2015-2019), Venture Partner at EQT Life Sciences Group BV (2001-2022), President at The Royal Netherlands Academy of Arts & Sciences (2012-2015), President at The International Society for Stem Cell Research (2017-2018), President at International Society of Differentiation, Inc. (2006-2008), Chief Scientific Officer at Hubrecht Organoid Technology Foundation (2014-2020), and Head-Pharma Research & Early Development at Roche Holding AG (2022-2025).
Education includes graduate (1982) and doctorate (1985) degrees from the University of Utrecht.

Aktiva positioner av Hans Clevers

Företag	Position	Start
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Direktör/Styrelseledamot	2019-03-05
University of Utrecht University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	1989-01-01

Alla aktiva positioner av Hans Clevers

Tidigare kända positioner av Hans Clevers

Företag	Position	Slut
ROCHE HOLDING AG	Direktör/Styrelseledamot	2022-03-18
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Medlem av Investeringskommittén	2022-02-28
Hubrecht Organoid Technology Foundation	Företagsledare/Principal	2020-01-01
Princess Maxima Centre For Pediatric Oncology	Teknisk/Vetenskaplig/F&U Direktör	2019-01-01
The International Society for Stem Cell Research The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.	President	2018-01-01

Se detaljerna i Hans Cleverss erfarenhet

Hans Cleverss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Hans Cleverss erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	14
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Roche Holding AG Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics	Health Technology
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Finance
University of Utrecht University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Commercial Services
The Royal Netherlands Academy of Arts & Sciences The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art	Commercial Services
The International Society for Stem Cell Research The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.
Hubrecht Institute Hubrecht Institute BiotechnologyHealth Technology Develops biology and stem cells	Health Technology
International Society of Differentiation, Inc. International Society of Differentiation, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and communication in fields of cell and molecular biology & oncology	Commercial Services
Surrozen Operating, Inc. Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines	Health Technology
Princess Maxima Centre For Pediatric Oncology
Hubrecht Organoid Technology Foundation
Xilis, Inc. Xilis, Inc. Medical SpecialtiesHealth Technology Develops droplet-based microfluidics technology devices for precision cancer diagnostics and drug development	Health Technology